Joint (JYNT) Expected to Announce Quarterly Earnings on Thursday

Joint (NASDAQ:JYNT) is expected to be issuing its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, March 12, 2026 at 5:00 PM ET.

Joint Stock Up 3.1%

Shares of Joint stock opened at $8.90 on Thursday. The company has a market cap of $132.34 million, a P/E ratio of -148.31 and a beta of 1.33. The firm’s 50 day moving average price is $9.30 and its 200-day moving average price is $9.18. Joint has a 52-week low of $7.50 and a 52-week high of $13.47.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. B. Riley Financial downgraded Joint from a “buy” rating to a “hold” rating in a research report on Friday, November 7th. Weiss Ratings reissued a “sell (e+)” rating on shares of Joint in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $17.00.

Insider Activity at Joint

In related news, major shareholder Charles E. Jobson bought 15,397 shares of the company’s stock in a transaction dated Thursday, February 12th. The shares were acquired at an average price of $8.50 per share, for a total transaction of $130,874.50. Following the completion of the transaction, the insider directly owned 1,645,294 shares in the company, valued at $13,984,999. This trade represents a 0.94% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders purchased 47,849 shares of company stock valued at $433,081 in the last three months. 27.90% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets increased its holdings in shares of Joint by 104.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company’s stock worth $28,000 after buying an additional 1,501 shares during the last quarter. JPMorgan Chase & Co. grew its position in Joint by 32.3% in the second quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock worth $86,000 after acquiring an additional 1,810 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Joint by 25.9% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock worth $95,000 after acquiring an additional 1,698 shares during the period. XTX Topco Ltd acquired a new stake in Joint during the fourth quarter worth $124,000. Finally, Wells Fargo & Company MN raised its position in Joint by 78.0% in the fourth quarter. Wells Fargo & Company MN now owns 15,476 shares of the company’s stock valued at $135,000 after purchasing an additional 6,784 shares during the period. 76.88% of the stock is owned by hedge funds and other institutional investors.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.